Back
Creative Realities Vs. Royalty Pharma PLC Industry Stock Comparison
Sell
26
CREX
Creative Realities
Last Price:
$1.93
Seasonality Move:
14.35%
Sell
28
RPRX
Royalty Pharma PLC
Last Price:
$31.38
Seasonality Move:
-2.74%
Sell
26
Creative Realities (CREX)
is a Sell
Is Creative Realities a Buy, Sell or Hold?
-
The current Creative Realities [CREX] share price is $1.96. The Score for CREX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
CREX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy, Sell or Hold?
-
The current Royalty Pharma PLC [RPRX] share price is $31.37. The Score for RPRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
RPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CREX Stock Price Chart
What is Creative Realities's stock price today?
-
The Creative Realities share price today is $1.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CREX is experiencing slight selling pressure.
RPRX Stock Price Chart
What is Royalty Pharma PLC's stock price today?
-
The Royalty Pharma PLC share price today is $31.37Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing slight selling pressure.
CREX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.54 | Buy |
Relative Strength Index (14 RSI): | 43.59 | Sell |
Chaikin Money Flow: | -13417 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.82 - 2.2) | Sell |
Bollinger Bands (100): | (2.09 - 3.41) | Sell |
RPRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 35.44 | Sell |
Chaikin Money Flow: | -282065 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.41 - 33.81) | Sell |
Bollinger Bands (100): | (26.01 - 32.63) | Buy |
CREX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2 | Sell |
20-day SMA: | 1.93 | Buy |
50-day SMA: | 2.27 | Sell |
200-day SMA: | 3.62 | Sell |
8-day EMA: | 1.65 | Buy |
20-day EMA: | 1.01 | Buy |
50-day EMA: | 0.49 | Buy |
200-day EMA: | 0.14 | Buy |
RPRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.84 | Sell |
20-day SMA: | 32.99 | Sell |
50-day SMA: | 32.42 | Sell |
200-day SMA: | 28.45 | Buy |
8-day EMA: | 32.44 | Sell |
20-day EMA: | 32.75 | Sell |
50-day EMA: | 31.89 | Sell |
200-day EMA: | 29.45 | Buy |
Creative Realities Earnings Growth & CREX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.18 per share, an increase this year of $0.62 per share, and an increase next year of $0.31 per share.
Creative Realities Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Royalty Pharma PLC Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |